Overview Fundamentals API Earnings EOD API Sample Code Pricing

Adlai Nortye Ltd. American Depositary Shares (ANL NASDAQ) stock market data APIs

$3.58 0.07(2%) as of July 17, 2024
Price chart is built with Anychart

Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the treatment of recurrent non-small cell lung cancer and urothelial cancer after anti-PD-1/PD-L1 treatments, recurrent triple-negative breast cancer, microsatellite stable colorectal cancer, and cervical cancer after standard of care treatments; and AN4005, an oral small-molecule PD-L1 inhibitor, which is in Phase I clinical trial to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and antigen-presenting cell modulator; AN1025, an oral small molecule degrader of ß-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was founded in 2004 and is based in Grand Cayman, the Cayman Islands.

Adlai Nortye Ltd. American Depositary Shares Financial Data Overview

388 M
36 900 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ANL',
Type: 'Common Stock',
Name: 'Adlai Nortye Ltd. American Depositary Shares',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG01HP11SV4',
CIK: '1944552',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2023-09-29',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Adlai Nortye Ltd. American Depositary Shares Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -69 412 000
  • Earnings Per Share -3.33
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Adlai Nortye Ltd. American Depositary Shares Earnings via APIs

  • Latest Release 2024-02-28
  • EPS/Forecast -0.38

Get Adlai Nortye Ltd. American Depositary Shares End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?